{"transactions":[{"id":1746757,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-11-08T21:22:37.000Z","date":"2023-11-07","kind":"sale","planned":false,"acquired":false,"shares":382,"price":12.65,"value":4832.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah."}],"balance_after":124511,"source":{"system":"sec-edgar","filing":"0001562180-23-007594","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007594/primarydocument.xml","form_type":"4"}},{"id":1789184,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-09-05T20:23:32.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":273,"price":21.8172,"value":5956.0956,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":124893,"source":{"system":"sec-edgar","filing":"0001562180-23-006680","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023006680/primarydocument.xml","form_type":"4"}},{"id":1833831,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-07-06T20:14:24.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":367,"price":35.28,"value":12947.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January1, 2023 through June 30, 2023.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023."}],"balance_after":125166,"source":{"system":"sec-edgar","filing":"0001562180-23-005760","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023005760/primarydocument.xml","form_type":"4"}},{"id":1965776,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:52:00.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":16909,"price":76.1594,"value":1287779.2946,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":124799,"source":{"system":"sec-edgar","filing":"0001562180-23-002580","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002580/primarydocument.xml","form_type":"4"}},{"id":1965775,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:52:00.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":2942,"price":76.1594,"value":224060.9548,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":141708,"source":{"system":"sec-edgar","filing":"0001562180-23-002580","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002580/primarydocument.xml","form_type":"4"}},{"id":1965774,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:52:00.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":1570,"price":76.1594,"value":119570.258,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":144650,"source":{"system":"sec-edgar","filing":"0001562180-23-002580","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002580/primarydocument.xml","form_type":"4"}},{"id":1969096,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T21:41:07.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":43246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":146220,"source":{"system":"sec-edgar","filing":"0001562180-23-002492","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002492/primarydocument.xml","form_type":"4"}},{"id":1969095,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T21:41:07.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":3936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":102974,"source":{"system":"sec-edgar","filing":"0001562180-23-002492","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002492/primarydocument.xml","form_type":"4"}},{"id":1969094,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T21:41:07.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":937,"price":75.2779,"value":70535.3923,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":99038,"source":{"system":"sec-edgar","filing":"0001562180-23-002492","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002492/primarydocument.xml","form_type":"4"}},{"id":1979489,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2023-03-02T22:00:09.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":31691,"price":76.97,"value":2439256.27,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 31,691 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":31691,"derivative":{"exercise_price":76.97,"exercise_date":"2024-02-28","expiration_date":"2033-02-27","underlying":"Ordinary Shares","underlying_shares":31691},"source":{"system":"sec-edgar","filing":"0001645113-23-000030","document":"wf-form4_167779437669900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000030/wf-form4_167779437669900.xml","form_type":"4"}},{"id":1979488,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T22:00:09.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1923,"price":76.3624,"value":146844.8952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":99975,"source":{"system":"sec-edgar","filing":"0001645113-23-000030","document":"wf-form4_167779437669900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000030/wf-form4_167779437669900.xml","form_type":"4"}},{"id":1979487,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T22:00:09.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":19055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":101898,"source":{"system":"sec-edgar","filing":"0001645113-23-000030","document":"wf-form4_167779437669900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000030/wf-form4_167779437669900.xml","form_type":"4"}},{"id":2058898,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-09T23:20:06.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":387,"price":108,"value":41796.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":82843,"source":{"system":"sec-edgar","filing":"0001645113-23-000008","document":"wf-form4_167330639201251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000008/wf-form4_167330639201251.xml","form_type":"4"}},{"id":2165637,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-09-06T21:12:39.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":269,"price":79.037,"value":21260.953,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":83230,"source":{"system":"sec-edgar","filing":"0001645113-22-000075","document":"wf-form4_166249873695422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000075/wf-form4_166249873695422.xml","form_type":"4"}},{"id":2210742,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:45:48.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":312,"price":59.075,"value":18431.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2022 through June 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022."}],"balance_after":83499,"source":{"system":"sec-edgar","filing":"0001645113-22-000059","document":"wf-form4_165723033557650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000059/wf-form4_165723033557650.xml","form_type":"4"}},{"id":2337539,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-11T21:54:08.000Z","date":"2021-07-31","kind":"exercise","acquired":false,"shares":3717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":3717,"derivative":{"exercise_price":0,"exercise_date":"2021-07-31","underlying":"Ordinary Shares","underlying_shares":3717},"source":{"system":"sec-edgar","filing":"0001645113-22-000031","document":"wf-form4_164703562615399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000031/wf-form4_164703562615399.xml","form_type":"4"}},{"id":2337538,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-11T21:54:08.000Z","date":"2022-03-09","kind":"sale","acquired":false,"shares":3669,"price":71.19,"value":261196.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amended total to correct prior mathematical error."}],"balance_after":83187,"source":{"system":"sec-edgar","filing":"0001645113-22-000031","document":"wf-form4_164703562615399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000031/wf-form4_164703562615399.xml","form_type":"4"}},{"id":2337537,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-11T21:54:08.000Z","date":"2021-07-31","kind":"exercise","acquired":true,"shares":3717,"price":154.01,"value":572455.17,"ownership":{"direct":true},"balance_after":85625,"source":{"system":"sec-edgar","filing":"0001645113-22-000031","document":"wf-form4_164703562615399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000031/wf-form4_164703562615399.xml","form_type":"4"}},{"id":2341834,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-09T21:56:11.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2481,"price":70.1,"value":173918.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":81908,"source":{"system":"sec-edgar","filing":"0001645113-22-000030","document":"wf-form4_164686295456528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000030/wf-form4_164686295456528.xml","form_type":"4"}},{"id":2341833,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-09T21:56:11.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":5294,"price":69.55,"value":368197.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":84389,"source":{"system":"sec-edgar","filing":"0001645113-22-000030","document":"wf-form4_164686295456528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000030/wf-form4_164686295456528.xml","form_type":"4"}},{"id":2347779,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:23:57.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":6231,"price":80.59,"value":502156.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Options to buy 6,231 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":6231,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":6231},"source":{"system":"sec-edgar","filing":"0001645113-22-000020","document":"wf-form4_164669542266568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000020/wf-form4_164669542266568.xml","form_type":"4"}},{"id":2347778,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:23:57.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":38027,"price":80.59,"value":3064595.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options to buy 38,027 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":38027,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":38027},"source":{"system":"sec-edgar","filing":"0001645113-22-000020","document":"wf-form4_164669542266568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000020/wf-form4_164669542266568.xml","form_type":"4"}},{"id":2347777,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:23:57.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":1914,"price":70.407,"value":134758.998,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":89683,"source":{"system":"sec-edgar","filing":"0001645113-22-000020","document":"wf-form4_164669542266568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000020/wf-form4_164669542266568.xml","form_type":"4"}},{"id":2347776,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:23:57.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":2632,"price":73.34,"value":193030.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":91597,"source":{"system":"sec-edgar","filing":"0001645113-22-000020","document":"wf-form4_164669542266568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000020/wf-form4_164669542266568.xml","form_type":"4"}},{"id":2347775,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:23:57.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":997,"price":74.498,"value":74274.506,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":94229,"source":{"system":"sec-edgar","filing":"0001645113-22-000020","document":"wf-form4_164669542266568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000020/wf-form4_164669542266568.xml","form_type":"4"}},{"id":2347774,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:23:57.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":21714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 21, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":95226,"source":{"system":"sec-edgar","filing":"0001645113-22-000020","document":"wf-form4_164669542266568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000020/wf-form4_164669542266568.xml","form_type":"4"}},{"id":2577224,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-07T20:32:50.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":30,"price":140.18,"value":4205.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":73512,"source":{"system":"sec-edgar","filing":"0001645113-21-000106","document":"wf-form4_163104675810103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000106/wf-form4_163104675810103.xml","form_type":"4"}},{"id":2577223,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-07T20:32:50.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":150,"price":139.238,"value":20885.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 150 shares in multiple trades at prices ranging from $138.81 to $139.78.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73542,"source":{"system":"sec-edgar","filing":"0001645113-21-000106","document":"wf-form4_163104675810103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000106/wf-form4_163104675810103.xml","form_type":"4"}},{"id":2577222,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-07T20:32:50.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":321,"price":138.273,"value":44385.633,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 321 shares in multiple trades at prices ranging from $137.75 to $138.56.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73692,"source":{"system":"sec-edgar","filing":"0001645113-21-000106","document":"wf-form4_163104675810103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000106/wf-form4_163104675810103.xml","form_type":"4"}},{"id":2577221,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-07T20:32:50.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":156,"price":138.232,"value":21564.192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":74013,"source":{"system":"sec-edgar","filing":"0001645113-21-000106","document":"wf-form4_163104675810103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000106/wf-form4_163104675810103.xml","form_type":"4"}},{"id":2611474,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-06T20:41:57.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":2063,"price":148.71,"value":306788.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":74169,"source":{"system":"sec-edgar","filing":"0001645113-21-000100","document":"wf-form4_162828248977664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000100/wf-form4_162828248977664.xml","form_type":"4"}},{"id":2614848,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-04T21:09:00.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":1654,"price":149.43,"value":247157.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":76232,"source":{"system":"sec-edgar","filing":"0001645113-21-000097","document":"wf-form4_162811132288298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000097/wf-form4_162811132288298.xml","form_type":"4"}},{"id":2638083,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-07-08T21:29:06.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":154,"price":137.122,"value":21116.788,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2021 through June 30, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2021."}],"balance_after":77886,"source":{"system":"sec-edgar","filing":"0001645113-21-000083","document":"wf-form4_162577972656216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000083/wf-form4_162577972656216.xml","form_type":"4"}},{"id":2671954,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-06-11T20:26:13.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":23540,"price":215,"value":5061100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":77732,"source":{"system":"sec-edgar","filing":"0001645113-21-000080","document":"wf-form4_162344315214063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000080/wf-form4_162344315214063.xml","form_type":"4"}},{"id":2725119,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-06T20:17:00.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":1290,"price":199.67,"value":257574.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":101272,"source":{"system":"sec-edgar","filing":"0001645113-21-000065","document":"wf-form4_162033218703219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000065/wf-form4_162033218703219.xml","form_type":"4"}},{"id":2727265,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-05T20:09:15.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-05-01","underlying":"Ordinary Shares","underlying_shares":2333},"source":{"system":"sec-edgar","filing":"0001645113-21-000063","document":"wf-form4_162024533376835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000063/wf-form4_162024533376835.xml","form_type":"4"}},{"id":2727264,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-05T20:09:15.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":1043,"price":200.856,"value":209492.808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":102562,"source":{"system":"sec-edgar","filing":"0001645113-21-000063","document":"wf-form4_162024533376835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000063/wf-form4_162024533376835.xml","form_type":"4"}},{"id":2727263,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-05T20:09:15.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":2333,"price":204.1,"value":476165.3,"ownership":{"direct":true},"balance_after":103605,"source":{"system":"sec-edgar","filing":"0001645113-21-000063","document":"wf-form4_162024533376835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000063/wf-form4_162024533376835.xml","form_type":"4"}},{"id":2797011,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-10T21:10:52.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":3524,"price":131.09,"value":461961.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":101272,"source":{"system":"sec-edgar","filing":"0001645113-21-000047","document":"wf-form4_161541063414261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000047/wf-form4_161541063414261.xml","form_type":"4"}},{"id":2797010,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-10T21:10:52.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2627,"price":130.806,"value":343627.362,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":104796,"source":{"system":"sec-edgar","filing":"0001645113-21-000047","document":"wf-form4_161541063414261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000047/wf-form4_161541063414261.xml","form_type":"4"}},{"id":2799956,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-09T21:17:26.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":13987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":13987},"source":{"system":"sec-edgar","filing":"0001645113-21-000042","document":"wf-form4_161532462367557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000042/wf-form4_161532462367557.xml","form_type":"4"}},{"id":2799955,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-09T21:17:26.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":4550,"price":131.53,"value":598461.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":107423,"source":{"system":"sec-edgar","filing":"0001645113-21-000042","document":"wf-form4_161532462367557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000042/wf-form4_161532462367557.xml","form_type":"4"}},{"id":2799954,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-09T21:17:26.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":13987,"price":7.15,"value":100007.05,"ownership":{"direct":true},"balance_after":111973,"source":{"system":"sec-edgar","filing":"0001645113-21-000042","document":"wf-form4_161532462367557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000042/wf-form4_161532462367557.xml","form_type":"4"}},{"id":2806186,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-05T22:43:33.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":2658,"price":137.554,"value":365618.532,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units vested on March 3, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":97986,"source":{"system":"sec-edgar","filing":"0001645113-21-000035","document":"wf-form4_161498420075158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000035/wf-form4_161498420075158.xml","form_type":"4"}},{"id":2806185,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-05T22:43:33.000Z","date":"2021-03-03","kind":"sale","acquired":false,"shares":2174,"price":150.78,"value":327795.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":100644,"source":{"system":"sec-edgar","filing":"0001645113-21-000035","document":"wf-form4_161498420075158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000035/wf-form4_161498420075158.xml","form_type":"4"}},{"id":2808836,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-04T22:46:31.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":20004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 20,004 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":20004,"derivative":{"exercise_price":153.09,"expiration_date":"2031-03-01","underlying":"Ordinary Shares","underlying_shares":20004},"source":{"system":"sec-edgar","filing":"0001645113-21-000027","document":"wf-form4_161489794759755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000027/wf-form4_161489794759755.xml","form_type":"4"}},{"id":2808835,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-04T22:46:31.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":10886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":102818,"source":{"system":"sec-edgar","filing":"0001645113-21-000027","document":"wf-form4_161489794759755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000027/wf-form4_161489794759755.xml","form_type":"4"}},{"id":2808834,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-04T22:46:31.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":912,"price":152.053,"value":138672.336,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Share Units vested on February 27, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":91932,"source":{"system":"sec-edgar","filing":"0001645113-21-000027","document":"wf-form4_161489794759755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000027/wf-form4_161489794759755.xml","form_type":"4"}},{"id":2820149,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T21:18:00.000Z","date":"2021-02-27","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-02-27","underlying":"Ordinary Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001645113-21-000025","document":"wf-form4_161471986510098.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000025/wf-form4_161471986510098.xml","form_type":"4"}},{"id":2820148,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:18:00.000Z","date":"2021-02-27","kind":"exercise","acquired":true,"shares":3086,"price":149.1,"value":460122.6,"ownership":{"direct":true},"balance_after":92844,"source":{"system":"sec-edgar","filing":"0001645113-21-000025","document":"wf-form4_161471986510098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000025/wf-form4_161471986510098.xml","form_type":"4"}},{"id":2997467,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-10-30T20:08:34.000Z","date":"2020-10-29","kind":"exercise","acquired":false,"shares":10037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":10037},"source":{"system":"sec-edgar","filing":"0001645113-20-000156","document":"wf-form4_160408850034942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000156/wf-form4_160408850034942.xml","form_type":"4"}},{"id":2997466,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-10-30T20:08:34.000Z","date":"2020-10-29","kind":"exercise","acquired":false,"shares":5913,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":14.37,"exercise_date":"2019-02-25","expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":5913},"source":{"system":"sec-edgar","filing":"0001645113-20-000156","document":"wf-form4_160408850034942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000156/wf-form4_160408850034942.xml","form_type":"4"}},{"id":2997465,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-10-30T20:08:34.000Z","date":"2020-10-29","kind":"exercise","acquired":false,"shares":14518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":7.48,"expiration_date":"2024-02-25","underlying":"Ordinary Shares","underlying_shares":14518},"source":{"system":"sec-edgar","filing":"0001645113-20-000156","document":"wf-form4_160408850034942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000156/wf-form4_160408850034942.xml","form_type":"4"}},{"id":2997464,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-10-30T20:08:34.000Z","date":"2020-10-29","kind":"exercise","acquired":true,"shares":10037,"price":11.46,"value":115024.02,"ownership":{"direct":true},"balance_after":89758,"source":{"system":"sec-edgar","filing":"0001645113-20-000156","document":"wf-form4_160408850034942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000156/wf-form4_160408850034942.xml","form_type":"4"}},{"id":2997463,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-10-30T20:08:34.000Z","date":"2020-10-29","kind":"exercise","acquired":true,"shares":5913,"price":14.37,"value":84969.81,"ownership":{"direct":true},"balance_after":79721,"source":{"system":"sec-edgar","filing":"0001645113-20-000156","document":"wf-form4_160408850034942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000156/wf-form4_160408850034942.xml","form_type":"4"}},{"id":2997462,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-10-30T20:08:34.000Z","date":"2020-10-29","kind":"exercise","acquired":true,"shares":14518,"price":7.48,"value":108594.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance reflects corrected total to reflect 11,175 shares sold and reported on Form 4 on June 27, 2019 but not deducted from prior totals."}],"balance_after":73808,"source":{"system":"sec-edgar","filing":"0001645113-20-000156","document":"wf-form4_160408850034942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000156/wf-form4_160408850034942.xml","form_type":"4"}},{"id":3033226,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-11T20:19:00.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":700,"price":86.0736,"value":60251.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On September 9, 2020, pursuant to a Rule 10b5-1 adopted by Mr. Shah, Mr. Shah sold 700 shares in multiple trades at prices ranging from $86.04 to $86.14.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":70465,"source":{"system":"sec-edgar","filing":"0001645113-20-000135","document":"wf-form4_159985552642125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000135/wf-form4_159985552642125.xml","form_type":"4"}},{"id":3033225,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-11T20:19:00.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":27621,"price":85.3926,"value":2358629.0046,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 9, 2020, pursuant to a Rule 10b5-1 adopted by Mr. Shah, Mr. Shah sold 27,621 shares in multiple trades at prices ranging from $85.00 to $85.98.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":71165,"source":{"system":"sec-edgar","filing":"0001645113-20-000135","document":"wf-form4_159985552642125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000135/wf-form4_159985552642125.xml","form_type":"4"}},{"id":3033217,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-11T20:13:40.000Z","date":"2020-09-02","kind":"sale","acquired":false,"shares":4200,"price":85.0129,"value":357054.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Form amended to reflect correct code.  Original filing incorrectly marked as P."}],"balance_after":98786,"source":{"system":"sec-edgar","filing":"0001645113-20-000133","document":"wf-form4a_159985520224267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000133/wf-form4a_159985520224267.xml","form_type":"4/A","original_submission_date":"2020-09-03"}},{"id":3039305,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-09-03T20:37:10.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":3779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 3,779 ordinary shares will vest and become exercisable in equal installments on each of September 1, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":3779,"derivative":{"exercise_price":84.68,"expiration_date":"2030-08-31","underlying":"Ordinary Shares","underlying_shares":3779},"source":{"system":"sec-edgar","filing":"0001645113-20-000124","document":"wf-form4_159916541528809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000124/wf-form4_159916541528809.xml","form_type":"4"}},{"id":3039304,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-03T20:37:10.000Z","date":"2020-09-02","kind":"purchase","acquired":false,"shares":4200,"price":85.0129,"value":357054.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On September 2, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 4200 shares in multiple trades at prices ranging from $85.00 to $85.02.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98786,"source":{"system":"sec-edgar","filing":"0001645113-20-000124","document":"wf-form4_159916541528809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000124/wf-form4_159916541528809.xml","form_type":"4"}},{"id":3039303,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2020-09-03T20:37:10.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":1968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on September 1, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":102986,"source":{"system":"sec-edgar","filing":"0001645113-20-000124","document":"wf-form4_159916541528809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000124/wf-form4_159916541528809.xml","form_type":"4"}},{"id":3067495,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-05T20:13:06.000Z","date":"2020-08-04","kind":"sale","acquired":false,"shares":2048,"price":76.81,"value":157306.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":101018,"source":{"system":"sec-edgar","filing":"0001645113-20-000116","document":"wf-form4_159665837256045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000116/wf-form4_159665837256045.xml","form_type":"4"}},{"id":3067494,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-05T20:13:06.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":1669,"price":76.406,"value":127521.614,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":103066,"source":{"system":"sec-edgar","filing":"0001645113-20-000116","document":"wf-form4_159665837256045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000116/wf-form4_159665837256045.xml","form_type":"4"}},{"id":3071378,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-03T21:39:25.000Z","date":"2020-07-31","kind":"exercise","acquired":false,"shares":3717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":3717,"derivative":{"exercise_price":0,"exercise_date":"2020-07-31","underlying":"Ordinary Shares","underlying_shares":3717},"source":{"system":"sec-edgar","filing":"0001645113-20-000111","document":"wf-form4_159649074278641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000111/wf-form4_159649074278641.xml","form_type":"4"}},{"id":3071377,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:39:25.000Z","date":"2020-07-31","kind":"exercise","acquired":true,"shares":3717,"price":76.17,"value":283123.89,"ownership":{"direct":true},"balance_after":104735,"source":{"system":"sec-edgar","filing":"0001645113-20-000111","document":"wf-form4_159649074278641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000111/wf-form4_159649074278641.xml","form_type":"4"}},{"id":3086570,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-08T20:25:30.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":325,"price":50.405,"value":16381.625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2020 through June 30, 2020.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2020."}],"balance_after":101018,"source":{"system":"sec-edgar","filing":"0001645113-20-000096","document":"wf-form4_159423991775624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000096/wf-form4_159423991775624.xml","form_type":"4"}},{"id":3158092,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-07T20:48:41.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":1149,"price":62.2,"value":71467.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 10, 2020, the reporting person filed a Form 4 that included information labeled \"Restricted Share Units\" in column 1, table 1.  All shares reported in that table should have been with respect to \"Ordinary Shares\" and all information in such Form 4 and all subsequent Form 4 reports refer to Ordinary Shares only."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":100693,"source":{"system":"sec-edgar","filing":"0001645113-20-000072","document":"wf-form4_158888450373702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000072/wf-form4_158888450373702.xml","form_type":"4"}},{"id":3161270,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-05T20:32:20.000Z","date":"2020-05-01","kind":"exercise","acquired":false,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":2333,"derivative":{"exercise_price":0,"exercise_date":"2019-05-01","underlying":"Ordinary Shares","underlying_shares":2333},"source":{"system":"sec-edgar","filing":"0001645113-20-000069","document":"wf-form4_158871072233446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000069/wf-form4_158871072233446.xml","form_type":"4"}},{"id":3161269,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-05T20:32:20.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":1184,"price":60.079,"value":71133.536,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":101842,"source":{"system":"sec-edgar","filing":"0001645113-20-000069","document":"wf-form4_158871072233446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000069/wf-form4_158871072233446.xml","form_type":"4"}},{"id":3161268,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-05T20:32:20.000Z","date":"2020-05-01","kind":"exercise","acquired":true,"shares":2333,"price":65.8,"value":153511.4,"ownership":{"direct":true},"balance_after":103026,"source":{"system":"sec-edgar","filing":"0001645113-20-000069","document":"wf-form4_158871072233446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000069/wf-form4_158871072233446.xml","form_type":"4"}},{"id":3217848,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-03-10T20:20:51.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":17500,"price":7.48,"value":130900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":14518,"derivative":{"exercise_price":7.48,"expiration_date":"2024-02-25","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001645113-20-000049","document":"wf-form4_158387163367218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000049/wf-form4_158387163367218.xml","form_type":"4"}},{"id":3217847,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-10T20:20:51.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":3245,"price":64.27,"value":208556.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":100693,"source":{"system":"sec-edgar","filing":"0001645113-20-000049","document":"wf-form4_158387163367218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000049/wf-form4_158387163367218.xml","form_type":"4"}},{"id":3217846,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-10T20:20:51.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":17500,"price":7.48,"value":130900.0,"ownership":{"direct":true},"balance_after":103938,"source":{"system":"sec-edgar","filing":"0001645113-20-000049","document":"wf-form4_158387163367218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000049/wf-form4_158387163367218.xml","form_type":"4"}},{"id":3217845,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-10T20:20:51.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":2906,"price":69.534,"value":202065.804,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on March 5, 2020.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":86438,"source":{"system":"sec-edgar","filing":"0001645113-20-000049","document":"wf-form4_158387163367218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000049/wf-form4_158387163367218.xml","form_type":"4"}},{"id":3224576,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-03-05T23:58:32.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":41690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 41,690 ordinary shares will vest and become exercisable in equal installments on each of March 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":41690,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":41690},"source":{"system":"sec-edgar","filing":"0001645113-20-000041","document":"wf-form4_158345269064978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000041/wf-form4_158345269064978.xml","form_type":"4"}},{"id":3224575,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-05T23:58:32.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":21623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":89344,"source":{"system":"sec-edgar","filing":"0001645113-20-000041","document":"wf-form4_158345269064978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000041/wf-form4_158345269064978.xml","form_type":"4"}},{"id":3224563,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-05T21:47:19.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":1485,"price":72.97,"value":108360.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":67721,"source":{"system":"sec-edgar","filing":"0001645113-20-000037","document":"wf-form4_158344482249133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000037/wf-form4_158344482249133.xml","form_type":"4"}},{"id":3238233,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-02T22:22:58.000Z","date":"2020-02-27","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":3086,"derivative":{"exercise_price":0,"exercise_date":"2019-02-27","underlying":"Ordinary Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001645113-20-000035","document":"wf-form4_158318776201211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000035/wf-form4_158318776201211.xml","form_type":"4"}},{"id":3238232,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-02T22:22:58.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":1601,"price":72.215,"value":115616.215,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":69206,"source":{"system":"sec-edgar","filing":"0001645113-20-000035","document":"wf-form4_158318776201211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000035/wf-form4_158318776201211.xml","form_type":"4"}},{"id":3238231,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-02T22:22:58.000Z","date":"2020-02-27","kind":"exercise","acquired":true,"shares":3086,"price":79.45,"value":245182.7,"ownership":{"direct":true},"balance_after":70807,"source":{"system":"sec-edgar","filing":"0001645113-20-000035","document":"wf-form4_158318776201211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000035/wf-form4_158318776201211.xml","form_type":"4"}},{"id":3241224,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T21:41:38.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":1500,"price":80.219,"value":120328.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 26, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 1500 shares in multiple trades at prices ranging from $80.01 to $80.51.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67721,"source":{"system":"sec-edgar","filing":"0001645113-20-000026","document":"wf-form4_158292608065025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000026/wf-form4_158292608065025.xml","form_type":"4"}},{"id":3241223,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T21:41:38.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":4332,"price":79.449,"value":344173.068,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 26, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 4332 shares in multiple trades at prices ranging from $79.00 to $79.99.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":69221,"source":{"system":"sec-edgar","filing":"0001645113-20-000026","document":"wf-form4_158292608065025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000026/wf-form4_158292608065025.xml","form_type":"4"}},{"id":3241222,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T21:41:38.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":2100,"price":78.678,"value":165223.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 26, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 2100 shares in multiple trades at prices ranging from $77.97 to $78.94.  The price reported above reflects the weighted average sale price.  Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73553,"source":{"system":"sec-edgar","filing":"0001645113-20-000026","document":"wf-form4_158292608065025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000026/wf-form4_158292608065025.xml","form_type":"4"}},{"id":3241221,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T21:41:38.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":5067,"price":81.156,"value":411217.452,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah."}],"balance_after":75653,"source":{"system":"sec-edgar","filing":"0001645113-20-000026","document":"wf-form4_158292608065025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000026/wf-form4_158292608065025.xml","form_type":"4"}},{"id":3246383,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-26T22:18:48.000Z","date":"2020-02-24","kind":"exercise","acquired":false,"shares":12999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-02-22","underlying":"Ordinary Shares","underlying_shares":12999},"source":{"system":"sec-edgar","filing":"0001645113-20-000015","document":"wf-form4_158275551073004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000015/wf-form4_158275551073004.xml","form_type":"4"}},{"id":3246382,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-26T22:18:48.000Z","date":"2020-02-24","kind":"exercise","acquired":true,"shares":12999,"price":88.26,"value":1147291.74,"ownership":{"direct":true},"balance_after":80720,"source":{"system":"sec-edgar","filing":"0001645113-20-000015","document":"wf-form4_158275551073004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000015/wf-form4_158275551073004.xml","form_type":"4"}},{"id":3387210,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-10-28T20:28:39.000Z","date":"2019-10-24","kind":"exercise","acquired":false,"shares":4580,"price":7.48,"value":34258.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options exercised were fully vested as of the date hereof."}],"balance_after":32018,"derivative":{"exercise_price":7.48,"expiration_date":"2024-02-25","underlying":"Ordinary Shares","underlying_shares":4580},"source":{"system":"sec-edgar","filing":"0001628280-19-012619","document":"wf-form4_157229448764330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828019012619/wf-form4_157229448764330.xml","form_type":"4"}},{"id":3387209,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-10-28T20:28:39.000Z","date":"2019-10-24","kind":"exercise","acquired":true,"shares":4580,"price":7.48,"value":34258.4,"ownership":{"direct":true},"balance_after":67721,"source":{"system":"sec-edgar","filing":"0001628280-19-012619","document":"wf-form4_157229448764330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828019012619/wf-form4_157229448764330.xml","form_type":"4"}},{"id":3429285,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-26T20:39:23.000Z","date":"2019-08-22","kind":"other","acquired":false,"shares":13835,"price":97.8,"value":1353063.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Private sale transaction."}],"balance_after":63141,"source":{"system":"sec-edgar","filing":"0001209191-19-047412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119047412/doc4.xml","form_type":"4"}},{"id":3445580,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-06T20:43:08.000Z","date":"2019-08-02","kind":"sale","acquired":false,"shares":1813,"price":85.23,"value":154521.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah."}],"balance_after":76976,"source":{"system":"sec-edgar","filing":"0001209191-19-044836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044836/doc4.xml","form_type":"4"}},{"id":3449221,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-08-02T20:13:24.000Z","date":"2019-07-31","kind":"exercise","acquired":false,"shares":3718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":7434,"derivative":{"exercise_price":0,"exercise_date":"2019-07-31","underlying":"Ordinary Shares","underlying_shares":3718},"source":{"system":"sec-edgar","filing":"0001209191-19-044234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044234/doc4.xml","form_type":"4"}},{"id":3449220,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to buy Ordinary Shares","published_at":"2019-08-02T20:13:24.000Z","date":"2019-07-31","kind":"exercise","acquired":false,"shares":5115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":15343,"derivative":{"exercise_price":34,"expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":5115},"source":{"system":"sec-edgar","filing":"0001209191-19-044234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044234/doc4.xml","form_type":"4"}},{"id":3449219,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-02T20:13:24.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":1905,"price":83.203,"value":158501.715,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah."}],"balance_after":78789,"source":{"system":"sec-edgar","filing":"0001209191-19-044234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044234/doc4.xml","form_type":"4"}},{"id":3449218,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-02T20:13:24.000Z","date":"2019-07-31","kind":"exercise","acquired":true,"shares":3718,"price":83.3,"value":309709.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah."}],"balance_after":80694,"source":{"system":"sec-edgar","filing":"0001209191-19-044234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044234/doc4.xml","form_type":"4"}},{"id":3449217,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-02T20:13:24.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":5115,"price":82.92,"value":424135.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah."}],"balance_after":76976,"source":{"system":"sec-edgar","filing":"0001209191-19-044234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044234/doc4.xml","form_type":"4"}},{"id":3449216,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-02T20:13:24.000Z","date":"2019-07-31","kind":"exercise","acquired":true,"shares":5115,"price":34,"value":173910.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah."}],"balance_after":82091,"source":{"system":"sec-edgar","filing":"0001209191-19-044234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044234/doc4.xml","form_type":"4"}},{"id":3453264,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to buy Ordinary Shares","published_at":"2019-07-30T19:57:52.000Z","date":"2019-07-26","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested as of the date hereof."}],"balance_after":25000,"derivative":{"exercise_price":19.25,"expiration_date":"2027-07-25","underlying":"Options to buy Ordinary Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-043642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119043642/doc4.xml","form_type":"4"}},{"id":3453263,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-07-30T19:57:52.000Z","date":"2019-07-26","kind":"sale","acquired":false,"shares":100,"price":80.06,"value":8006.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $78.97 to $79.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":76976,"source":{"system":"sec-edgar","filing":"0001209191-19-043642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119043642/doc4.xml","form_type":"4"}},{"id":3453262,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":108466,"kind":"person","name":"Shah Pritesh","position":1,"cik":"0001744884","reported_name":"Shah Pritesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-07-30T19:57:52.000Z","date":"2019-07-26","kind":"sale","acquired":false,"shares":3857,"price":79.411,"value":306288.227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $77.94 to $78.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":77076,"source":{"system":"sec-edgar","filing":"0001209191-19-043642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119043642/doc4.xml","form_type":"4"}}],"next_cursor":"2019-07-30T19:57:52.000000Z,3453262"}